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1. Experimental details for the synthesis of all compounds reported in the paper 
Chemical Synthesis. General Procedures and Materials. Unless otherwise stated, all reagents were 
purchased from chemical suppliers and used without further purification, room temperature corresponds to 
ambient temperature and yields refer to spectroscopically and chromatographically pure compounds. 
Reactions were monitored by thin layer chromatography (TLC) performed on commercially available glass 
plates pre-coated with Merck silica gel 60 F254 or Merck silica gel 60 RP-18 F254s. Visualisation was by the 
quenching of UV fluorescence (λmax= 254/365 nm) and by staining with iodine or potassium permanganate. 
All flash chromatography was carried out using slurry packed Merck 9325 Keiselgel 60 or Aldrich C18-reverse 
phase silica gel. Melting points were obtained using a Gallenkamp Melting Point apparatus and are 
uncorrected.  
NMR spectra were recorded using an internal deuterium lock at ambient probe temperatures on a Bruker 
DRX-400 (400 MHz) instrument. Chemical shifts (δ) are quoted in ppm, to the nearest 0.01 ppm (for 1H NMR 
spectra), or 0.1 ppm (for 13C NMR spectra), and are referenced to the residual non-deuterated solvent peak. 
Coupling constants (J) are reported in Hertz (Hz) to the nearest 0.5 Hz. Data are reported as follows: 
chemical shift, multiplicity (br= broad; s= singlet; d= doublet; t= triplet; m= multiplet, or as a combination of 
these, e.g. dd, dt, etc.), integration, assignment and coupling constant(s). Assignments were determined 
either on the basis of unambiguous chemical shift or coupling pattern, and analogy to fully interpreted 
spectra for related compounds. Diastereotopic protons are assigned as CH-H. 
Liquid chromatography–mass spectrometry (LC-MS) experiments were performed on Waters Aquity UPLC I-
CLASS coupled with Waters LCT Premier (operating in ES+ or ES- mode). High resolution masses (HR-MS) 
for accurate mass determination were performed on the same equipment and samples referenced against 
Leucine Enkaphalin or Sulfadimethoxine. For analytical HPLC, a Waters BEH Acquity C18 (50mm x 2.1mm) 
column was used and the mobile phase was composed of solvent A (99.9% Water, 0.1% Formic Acid) and 
solvent B (99.9% Acetonitrile, 0.1% Formic Acid) used in a linear gradient (time= 0 min, 95%A and 5%B; 
time= 3.2 min, 5%A and 95%B; time= 3.5 min, 95%A and 5%B; total run time 4 min). The sample solutions 
were prepared at a concentration of 0.1 mg/1 mL. The injection volume was 10µL, the flow rate was 
0.5mL/min, the column temperature was 40 °C, and the UV detector wavelength was fixed at 210 to 280 nm. 
The values of retention time (tR) are given in minutes. Electron spray ionisation (ESI) conditions were as 
follow: 2kV (ES+) and 2.5kV (ES-) capillary voltage; 30 V (ES+) and 150 V (ES+) sample cone voltage; 
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2.1kV MCP Voltage; 350 °C desolvation temperature; 120 °C source temperature; 10 L/h cone gas flow (N2); 
400 L/h desolvation gas flow (N2). Mass values are reported within the error limits of ±5 ppm mass units.  
UV–vis spectra of the probes were recorded using a Perkin-Elmer Lambda 25 UV-vis spectrophotometer. 
Fluorescence emission spectra were obtained on a Varian Cary Eclipse fluorescence spectrofluorimeter 
using 0.05-0.1 mg/mL sample solutions and 1.0 cm path-length quartz cuvettes (1.0-3.0 mL) at 25°C. 
Spectra were not corrected for light intensity or detector sensitivity. Data were recorded on-line and analysed 
by Excel software. 
N-succinimidyl ester of 7-methoxycoumarin-3-carboxylic acid (4) and 3-methoxy-5-oxocyclohex-3-ene-1-
carboxylic acid (9) were prepared following literature procedures [1,2]. 
 
Synthesis of tert-butyl-[4-(7-methoxy-2-oxo-2H-chromene-3-carboxamido)butyl]carbamate, 6. DMAP (13.2 
mg, 0.11 mmol), 4 [1] (327.0 mg, 1.03 mmol) and DIPEA (0.38 mL, 2.16 mmol) were sequentially added to a 
stirred solution of 5 (0.21 mL, 1.08 mmol) in 8 mL of anhydrous CH2Cl2 and the reaction was carried out 
under N2 for 5 h at room temperature. After evaporation of the solvent, the crude mixture was purified by 
flash column chromatography using CH2Cl2/MeOH/NH4OH 95:5:0.5 as eluent. Yield = 400.0 mg, 1.02 mmol, 
99.5%; mp= 153-54°C. 1H NMR (400 MHz, CDCl3) δ 8.74 (s, 1H, Ar), 8.71 (exch br t, 1H, NH), 7.51 (d, 1H, 
Ar, J= 8.8 Hz), 6.86 (dd, 1H, Ar, J= 6.4 Hz, J= 2.4 Hz), 6.78 (d, 1H, Ar, J= 2.4 Hz), 4.71 (exch br s, 1H, NH), 
3.85 (s, 3H, OCH3), 3.40 (q, 2H, NCH2, J= 6.4 Hz), 3.11 (q, 2H, NCH2, J= 6.0 Hz), 1.50-1.62 (m, 4H, 
NCH2(CH2)2), 1.37 (s, 9H, Boc). LC-MS (ESI): m/z calcd. for C20H26N2O6 390.4 (MW), found 391.2 [M+H]+, 
413.2 [M+Na]+; tR= 2.1. HR-MS (ESI): m/z calcd. for C20H27N2O6 391.1869 [M+H]+, found 391.1872. 
 
Synthesis of N-(4-aminobutyl)-7-methoxy-2-oxo-2H-chromene-3-carboxamide, 7. Intermediate 6 (400.0 mg, 
1.02 mmol) was dissolved in CH2Cl2 (3.0 mL) and 1.0 mL of TFA was slowly added. The reaction was stirred 
at room temperature for 1.5 h and evaporated under vacuum. Excess of TFA was removed by five 
consecutive co-evaporations with CH2Cl2 to recover pure product 7 as TFA salt. Yield = 400.0 mg, 0.99 
mmol, 96.8%; mp = 229-31°C. 1H NMR (400 MHz, CD3OD) δ 9.11 (exch br t, 1H, NH), 8.81 (s, 1H, Ar), 7.76 
(d, 1H, Ar, J= 8.8 Hz), 7.04 (dd, 1H, Ar, J= 6.4 Hz, J= 2.4 Hz), 7.01 (d, 1H, Ar, J= 2.4 Hz), 3.94 (s, 3H, 
OCH3), 3.48 (q, 2H, NCH2, J= 4.0 Hz), 2.99 (t, 2H, NCH2, J= 6.8 Hz), 1.70-1.75 (m, 4H, NCH2(CH2)2). LC-MS 
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(ESI): m/z calcd. for C15H18N2O4 290.3 (MW), found 291.1 [M+H]+, 313.1 [M+Na]+; tR= 1.1. HR-MS (ESI): m/z 
calcd. for C15H19N2O4 291.1345 [M+H]+, found 291.1352.   
 
Synthesis of 7-methoxy-N-[4-(3-methoxy-5-oxocyclohex-3-ene-1-carboxamido)butyl]-2-oxo-2H-chromene-3-
carboxamide, 10. HOBt (134.0 mg, 0.99 mmol), Et3N (0.19 mL, 1.39 mmol) and EDC (0.24 mL, 1.39 mmol) 
were sequentially added to a solution of 9 [2] (236.5 mg, 1.39 mmol) in anhydrous DMF (4.0 mL). A solution 
of 7 (TFA salt, 400.0 mg, 0.99 mmol) in anhydrous DMF (8 mL) was drop-wise added and the reaction was 
stirred under N2 at room temperature for 24 h. DMF was evaporated and the crude mixture was purified by 
flash column chromatography using CH2Cl2/MeOH (gradient 95:5→9:1) as eluent, to afford 10 as a white 
solid. Yield = 438.0 mg, 0.99 mmol, 99.9%; mp= 207-09°C. 1H NMR (400 MHz, CD3OD) δ 8.80 (s, 1H, Ar), 
7.75 (d, 1H, Ar, J= 8.4 Hz), 7.00-7.04 (m, 2H, Ar), 5.41 (s, 1H, CHCOCH3), 3.94 (s, 3H, PhOCH3), 3.76 (s, 
3H, CH2COCH3), 3.44 (t, 2H, NCH2, J= 6.4 Hz), 3.24 (t, 2H, NCH2, J= 6.8 Hz), 2.95-3.01 (m, 1H, NHCOCH), 
2.71-2.78 (m, 1H, COCHCH-H), 2.42-2.58 (m, 3H, COCHCH2 + COCHCH-H), 1.57-1-67 (m, 4H, 
NCH2(CH2)2). LC-MS (ESI): m/z calcd. for C23H26N2O7 442.5 (MW), found 443.2 [M+H]+, 465.2 [M+Na]+; tR= 
1.5. HR-MS (ESI): m/z calcd. for C23H27N2O7 443.1818 [M+H]+, found 443.1807. 
 
Synthesis of N-[4-(3-hydroxy-5-oxocyclohex-3-ene-1-carboxamido)butyl]-7-methoxy-2-oxo-2H-chromene-3-
carboxamide, 1. LiOH (21.6 mg, 0.90 mmol) was added to a stirred solution of 10 (100.0 mg, 0.22 mmol) in 
THF/MeOH/H2O (4:1.6:1.6 mL). After 16 h at room temperature, solvents were evaporated. The crude 
mixture was suspended in H2O and acidified to pH= 4 using 6N HCl. Lastly, H2O was evaporated and the 
residue purified by RPh column chromatography using MeOH/H2O 1:1 as eluent, to obtain 1 as a yellowish 
solid. Yield = 89.0 mg, 0.21 mmol, 94.4%; mp= 99-101°C. 1H NMR (400 MHz, CD3OD) δ 8.92 (exch br s, 1H, 
NH), 8.79 (s, 1H, Ar), 7.75 (d, 1H, Ar, J= 8.8 Hz), 7.59 (exch br s, 1H, NH), 7.03 (dd, 1H, Ar, J= 6.4 Hz, J= 
2.4 Hz), 7.00 (d, 1H, Ar, J= 2.4 Hz), 5.41 (s, 1H, CHCOH), 3.94 (s, 3H, OCH3), 3.44 (t, 2H, NCH2, J= 6.8 Hz), 
3.24 (t, 2H, NCH2, J= 6.4 Hz), 2.97-3.01 (m, 1H, NHCOCH), 2.70-2.78 (m, 1H, COCHCH-H), 2.46-2.55 (m, 
3H, COCHCH2 + COCHCH-H), 1.58-1-67 (m, 4H, NCH2(CH2)2). 13C NMR (100 MHz, CD3OD) δ 180.2 (C), 
174.9 (C), 166.8 (C), 164.3 (C), 162.9 (C), 158.2 (C), 149.4 (CH), 132.5 (CH), 120.5 (C), 115.6 (C), 115.2 
(CH), 113.6 (C), 102.2 (CH), 101.3 (CH), 56.8 (CH3), 41.3 (CH), 40.3 (CH2), 40.1 (CH2), 39.8 (CH2), 32.6 
(CH2), 27.8 (CH2), 27.7 (CH2). LC-MS (ESI): m/z calcd. for C22H24N2O7 428.4 (MW), found 429.2 [M+H]+, 
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451.1 [M+Na]+; tR= 1.5. HR-MS (ESI): m/z calcd. for C22H25N2O7 429.1662 [M+H]+, found 429.1671. UV-vis 
(H2O): λ/nm 348. Fluorescence (H2O): λmax(ex) 348 nm, λmax(em) 403 nm. 
 
Synthesis of 5-{[2-(3-methoxy-5-oxocyclohex-3-ene-1-carboxamido)ethyl]amino} naphthalene-1-sulfonic 
acid, 12. HOBt (200.5 mg, 1.48 mmol), Et3N (0.29 mL, 2.12 mmol) and EDC (0.37 mL, 2.12 mmol) were 
added to a stirred solution of 9 [2] (360.0 mg, 2.12 mmol) in 5 mL of anhydrous DMF under N2. A suspension 
of 11 (394.0  mg, 1.48 mmol) in anhydrous DMF (5 mL) was subsequently added and the reaction was 
carried out for 2 days at room temperature. After removal of the solvent under vacuum, the crude mixture 
was purified by two consecutive flash column chromatography (eluents: CH2Cl2/MeOH/ AcOH 8:2:0.2 and 
CH2Cl2/MeOH 8:2), to obtain 12 as a yellowish solid. Yield = 590.0 mg, 1.41 mmol, 95.3%; mp= 270-73°C 
(130 °C, dec). 1H NMR (400 MHz, CD3OD) δ 8.11-8.18 (m, 3H, Ar), 7.37-7.42 (m, 2H, Ar), 6.68 (d, 1H, Ar, J= 
7.6 Hz), 5.39 (d, 1H, COCHCO, J= 1.2 Hz), 3.71 (s, 3H, OCH3), 3.51-3.63 (m, 2H, NCH2), 3.41 (t, 2H, NCH2, 
J= 6.4 Hz), 2.98-3.06 (m, 1H, CH2CH), 2.71-2.78 (m, 1H, COCH-H), 2.44-2.61 (m, 3H, COCH-H + 
CH2COCH3), 1.93 (exch br s, 1H, OH). 13C NMR (100 MHz, CD3OD) δ 200.6 (C), 180.1 (C), 175.9 (C), 145.5 
(C), 142.0 (C), 131.6 (C), 128.6 (CH), 126.8 (CH), 125.7 (C), 125.4 (CH), 123.7 (CH), 116.5 (CH), 105.1 
(CH), 102.3 (CH), 56.9 (CH3), 45.0 (CH2), 41.4 (CH), 40.2 (CH2), 39.8 (CH2), 32.7 (CH2).  LC-MS (ESI): m/z 
calcd. for C20H22N2O6S 418.5 (MW), found 419.2 [M+H]+; tR= 0.9. 
 
Synthesis of 5-{[2-(3-hydroxy-5-oxocyclohex-3-ene-1-carboxamido)ethyl]amino} naphthalene-1-sulfonic acid, 
2. Ammonium cerium(IV) nitrate  (CAN, 14.4  mg, 0.03 mmol) was added to a solution of 12 (110.0 mg, 0.26 
mmol) in CH3CN/H2O 1:1 (8.0 mL) and the reaction was stirred for 6 h at reflux (100 °C). After cooling, the 
solvent was evaporated under vacuum and the crude was purified through flash column chromatography 
using CH2Cl2/MeOH/NH4OH (eluent: gradient 8:2:0.2 → 7:3:0.3) to obtain 2 as a yellow solid. Yield = 51.5 
mg, 0.13 mmol, 49.0%; mp= 114-16°C. 1H NMR (400 MHz, CD3OD) δ 8.12-8.18 (m, 3H, Ar), 7.39 (t, 2H, Ar, 
J= 7.6 Hz), 6.68 (d, 1H, Ar, J= 7.6 Hz), 5.19 (s, 1H, COCHCO), 3.61-3.65 (m, 1H, NCH-H), 3.47-3.53 (m, 1H, 
NCH-H), 3.42 (t, 2H, NCH2, J= 5.6 Hz), 2.82-2.93 (m, 1H, CH2CH), 2.56-2.63 (m, 1H, COCH-H), 2.42-2.49 
(m, 1H, COCH-H), 2.23-2.35 (m, 2H, CH2COH), 1.95 (exch br s, 1H, S-OH). 13C NMR (100 MHz, CD3OD) δ 
197.3 (C), 176.5 (C), 171.3 (C), 145.8 (C), 142.1 (C), 131.7 (C), 128.7 (CH), 126.9 (CH), 125.9 (C), 125.6 
(CH), 123.8 (CH), 116.5 (CH), 105.3 (CH), 45.1 (CH2), 42.4 (CH), 40.1 (CH2), 39.1 (CH2), 32.0 (CH2). IR νmax 
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(neat)/cm-1: 3325 cm-1 (OH), 2923 cm-1 (NH), 2854 cm-1 (NH), 2823 cm-1 (NH), 1641 cm-1 (C=O), 1533 
(C=O), 1365 (S=O). LC-MS (ESI): m/z calcd. for C19H20N2O6S 404.4 (MW), found 404.2 [M]+; tR= 0.8. UV-vis 
(H2O): λ/nm 337. Fluorescence (H2O): λmax(ex) 335 nm, λmax(em) 500 nm. 
 
2. Full spectral characterization for intermediates 6-10 and optical probe 1 
tert-Butyl-[4-(7-methoxy-2-oxo-2H-chromene-3-carboxamido)butyl]carbamate, 6 
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N-(4-Aminobutyl)-7-methoxy-2-oxo-2H-chromene-3-carboxamide, 7 
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7-Methoxy-N-[4-(3-methoxy-5-oxocyclohex-3-ene-1-carboxamido)butyl]-2-oxo-2H-chromene-3-carboxamide, 
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N-[4-(3-Hydroxy-5-oxocyclohex-3-ene-1-carboxamido)butyl]-7-methoxy-2-oxo-2H-chromene-3-
carboxamide,1 
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3. Full spectral characterization for intermediate 12 and optical probe 2           
5-{[2-(3-Methoxy-5-oxocyclohex-3-ene-1-carboxamido)ethyl]amino}naphthalene-1-sulfonic acid, 12                               
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5-{[2-(3-hydroxy-5-oxocyclohex-3-ene-1-carboxamido)ethyl]amino} naphthalene-1-sulfonic acid, 2 
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Figure S1. Emission spectra of probe 1 in the absence/presence of H2O2 (30 min. incubation). a) 
Fluorescence emission of 1 (1mM) in DPBS. b) Fluorescence emission of 1 (1mM) + 30% H2O2 (1mM) in 
DPBS after 30 minutes. 
 
 
4. Cell culture protocols  
MCF7 and MDA-MB-231 were obtained from American Type Culture Collection and were grown following 
the manufacturer’s instruction in complete DMEM-high glucose (Sigma-Aldrich, #D6429) supplemented with 
10 % FBS (Sigma-Aldrich,#F6178) (DMEM+) in a 5% CO2 humidified atmosphere at 37 °C. Cells were 
typically sub-cultured every two days or around 80 % confluence with a split ratio of 1:4 to 1:6. For the 
microscopy experiments, cells were seeded at ≈ 50 % confluence on glass coverslips in a 96-well plate 
format (Greiner Sensoplate™,  borosilicate glass, thickness=175 µM, black polystyrene plate, Sigma-Aldrich, 
#M4187) and allowed to adhere for at least 15 hours in DMEM+ in a humidified incubator with a 5 % CO2 
atmosphere at 37 °C. 96-well plate glass bottom was pre-treated overnight at 4 °C with 20 µg mL-1 of 
fibronectin from bovine plasma (Sigma-Aldrich, #F1141) in Dulbecco Phosphate Buffer Saline with Ca2+/Mg2+ 
(DPBS, Sigma-Aldrich, #D8662). The fibronectin solution was removed immediately prior to cell seeding; the 
coverslips were washed twice with DPBS and pre-filled with DMEM+. All the experiments to assess the 
sulfenylation in live cells were performed at 37 °C in a humidified incubator with a 5% CO2 atmosphere. 
 
5. Image analysis 
Acquired images were analysed for quantitative single cell signal intensity with an in-house developed script 
in Fiji software (National Institute of Health, USA; http://imagej.nih.gov/ij; v 1.49m) [3], following the protocol 
described in the Results and Discussion section (Figure S2 and ‘macro run code’ files, Supporting 
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Information). The threshold value for the identification of the cells above the background is defined by 
(𝑚𝑒𝑎𝑛𝑏𝑘𝑔 + (2 × 𝑠𝑡𝑑𝑒𝑣𝑏𝑘𝑔) where the 𝑚𝑒𝑎𝑛𝑏𝑘𝑔 is the mean signal intensity of the area without cells and 
𝑠𝑡𝑑𝑒𝑣𝑏𝑘𝑔 is the standard deviation of the mean signal intensity measured for the area without cells. From the 
mask of identified cell by the Analyze particle tool in Fiji, the signal from each individual cell is integrated to 
obtain the mean pixel intensity (𝐼𝑛𝑡𝑀𝑒𝑎𝑛𝑖 =  
∑ 𝐼𝑛𝑡𝑃𝑥𝐴𝑟𝑒𝑎𝑖
𝐴𝑟𝑒𝑎𝑖
; where 𝐼𝑛𝑡𝑀𝑒𝑎𝑛𝑖 is the mean intensity of a specific 
single cell "𝑖", 𝐴𝑟𝑒𝑎𝑖 is the area in square pixels identified for the single cell "𝑖" and ∑ 𝐼𝑛𝑡𝑃𝑥𝐴𝑟𝑒𝑎𝑖  is the total 
sum of pixel intensities in the 𝐴𝑟𝑒𝑎𝑖 for the single cell "𝑖".   
 
 
Figure S2. Schematic representation of the Fiji (free to download at http://imagej.nih.gov/ij) developed 
protocol for the quantification of single cell signal intensity in the channel of interest. As an example, the 
FITC and DAPI channel acquisition is shown in the scheme, although the script can handle single (e.g. FITC 
only) or multiple (e.g. DAPI, FITC, Cy5) channels for the identification of cell boundaries and further 
quantitative analysis. a) Images acquired in the channels of interest at 16-bit (DAPI and FITC for nuclei and 
sulfenic acid (probe 2) are flattened and background subtracted; b) from every fluorescent channel, a 8-bit 
mask with white objects above black background above a defined threshold is obtained; c) the masks from 
every channel are combined to obtain the mask for the total cell surface and submitted to particle 
identification algorithm in Fiji; d) an output mask of the identified single cell with black objects above the 
white background is obtained; e) the latter mask is over-imposed to the 16-bit images in every channel and 
the signal from each individual cell is integrated to obtain the mean pixel; f) mean pixel intensities obtained 
for single cells in the channel of interest, e.g. FITC for sulfenic acid measured with probe 2, are plotted as 
frequency plots for the evaluation of the mean signal across the cell population (dash red line). 
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Figure S3. Mean intensity signal from MCF7 cells treated with increasing concentrations (i.e. 0.05, 0.2 and 1 
mM) of probes 1 (DAPI channel) and 2 (FITC channel) with auto-fluorescence removed in all the relevant 
channels. Blue bars represent the basal levels of SOH measured and the red bars the SOH levels after 
treatment with 1 mM H2O2 in DPBS for 30 minutes at 37°. Error bars are the standard errors of the mean.   
 
Figure S4. Evaluation of the MCF7 cell’s proliferation before and after the treatment with probe 2 (1 mM). 
Top: representative bright field images obtained with a 10x objective corresponding to the times indicated on 
the plot at treatment (t0), 24 hours after treatment (t1) and 60 hours after treatment (t2) for the control (top 
row) and the probe 2 treated (bottom row) samples. Bottom: cell’s growth profile obtained by measuring the 
percentage of area occupied by adhered cells in respect to the total area observed. Treated (blue line for 
probe 1 and green line for probe 2, 1 mM) and control cells (red line) were prepared in triplicate and imaged 
every 12 hours in five random locations for each experiment. Cells were allowed to adhere for 24 hours 
before incubation with probe 2 was carried out (time zero = t0). Standard deviation at each time point for the 
percentage of area occupied by cells was ≤10% 
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Abstract 
Reactive oxygen species (ROS) are considered versatile second messengers mediating fundamental 
biological functions. A molecular pathway by which ROS determine functional diversity is the 
selective oxidation of cysteine residues to form sulfenic acid (SOH) products, known as 
sulfenylation or S-hydroxylation. This crucial post-translational modification is responsible for the 
alteration of protein stability, function and signalling. Despite considerable advances on the 
identification of sulfenic residues on individual proteins, improved methods are needed for direct 
visualization and accurate quantification of the extent of total protein sulfenylation. Herein we 
present the synthesis of two new cell-permeable fluorescent probes containing dimedone (a cyclic 
β-diketone with high specificity for sulfenic acids), and apply them to study oxidation processes in 
individual cells via microscopy. The low cytotoxicity, cell permeability and optical features of the 
probes allowed us to visualize and quantify the oxidation of cysteine residues in live cells during 
H2O2-mediated oxidative burst (i.e. exogenously administered H2O2). We present preliminary 
cellular imaging studies with these probes to analyse the oxidation process in cells treated with the 
anticancer drug cisplatin.  
 
Keywords: optical probe, dimedone, sulfenic acid, cellular microscopy, fluorescence co-
localization, cisplatin 
 
 
 
 
 
1. Introduction 
Reactive oxygen species (ROS) can be generated in response to different stimuli, such as cytokines, 
G-protein coupled receptor (GPCR) agonists and growth factors, contributing to the so-called ‘redox 
imbalance’ due to endogenous oxidative stress in live cells [1]. H2O2, HO· and O2·- are the most 
common ROS species, being widely involved in bio-macromolecule damage and influencing aging-
associated processes, as well as pathological conditions related to cancer and neurodegenerative 
disorders [2-5]. Cells are commonly exposed to increasing oxidative stress mainly due to 
mitochondrial disorders, cancer progression and raised metabolic activity [6,7]. It is well-
established that the overproduction of ROS may lead to aberrant oxidations of cellular components 
affecting protein-protein interaction and resulting in different dysfunctions related to homeostatic 
cell growth, trafficking and apoptosis [6]. For example, elevated ROS can produce aberrant 
proliferation signals and, consequently, promote malignancy and tumour growth [8]. More recent 
studies also indicate that ROS can have a role as second messengers in intracellular biochemical 
mechanisms and pathways [7], often associated to the chemo-selective oxidation of cysteines’ thiol 
in proteins [9].  
Sulfenic acids (SOHs) have been often found as first products of oxidation during the reaction of a 
cysteine thiol/thiolate and ROS. They are crucial players in redox-mediated signalling and protein 
function, although sulfinic (SO2H) or sulfonic (SO3H) acids can also be formed [10-12].
 In general, 
SOHs in proteins are transient and labile, allowing further reversible reduction/oxidation of the 
intermediates, which in turn could either restore the original thiol or react with local nucleophiles 
(e.g. to form disulfides and sulfenyl-amide derivatives) [13-15]. Due to  the highly reactive nature 
of SOHs, understanding their physiological roles and quantifying their formation in live cells 
remains a challenge. On the other hand, considering their wide biological relevance, there is 
increasing evidence that a deeper knowledge of the connection between ROS signalling and 
cysteine sulfenic oxidation could lead to the development of therapeutics that target diseases on the 
basis of the cellular redox status [16,17]. 
A number of previous reports have shown the use of dimedone as a valuable reactive group to 
generate chemical tools which are selective for sulfenic acid detection in cells and tissues (i.e. no 
cross reaction with other functional groups in proteins, as well as with different cysteine oxoforms) 
[18-21]. The majority of these probes are based on the use of biotin-dimedone constructs both pre-
assembled (e.g. DCP-Bio1®) or in cell-coupled (i.e. azide-tagged analogues for click strategies) [22-
24]; these in turn have been used to visualize SOH-modified proteins via ‘bulk analysis’ in cell 
lysate (e.g. ELISA or gel-electrophoresis) and Western blot (i.e. affinity enrichment with 
streptavidin) [25], or by mass spectrometry analysis of labelled proteins [26,27]. Although biotin-
dimedone probes have proven to be useful to study protein sulfenylation, they have limitations 
mainly due to the size of the streptavidin (not allowing live cell measurements) and difficulties in 
safely interpreting all streptavidin affinity-purified proteins as sulfenic products [25]. A strategy to 
address this is to use dimedone directly attached to a fluorophore tag for direct SOH visualization. 
While some examples of this type of probe have been reported [21,28,29], detailed studies to 
determine their effective application in cell analysis are still sparse.  
Herein we report the synthesis of two new cell-permeable and non-toxic optical probes (Figure 1) to 
study SOH formation. We show that these probes can detect cysteine sulfenic acid in live cells (i.e. 
MCF7 and MDA-MB-231) by fluorescence microscopy, which allowed us to quantify and monitor 
cellular localization of oxidised product formation among different cellular compartments during a 
burst of H2O2 (as archetypal ROS species). Our new probes make use of the well-known reaction 
between sulfenic groups and a range of 5- and 6-membered cyclic β-diketones (e.g. dimedones) to 
form the corresponding thioether (see Figure 1) [30]. 
As a proof of concept, we have additionally applied our new optical probes to detect for the first 
time the increase of sulfenic acid products in live cells following administration of the anticancer 
agent cisplatin [31], known to induce mitochondrial damage and impairment of respiration and thus 
resulting in the production of endogenous ROS [32-34]. These studies allowed the quantification of 
drug-induced SOH levels, proposing the current approach as a useful means to monitor oxidative 
imbalance in therapeutically relevant contexts. 
 
Figure 1. Optical probes and rational design of the SOH-targeting method (F = fluorogenic residue 
to allow cellular imaging).  
 
2. Material and Methods 
All the experimental details for the synthesis and characterisation of new compounds reported in 
this paper, the cell culture protocols and image analysis methods, can be found in the 
Supplementary Information. 
2.1 Detection of sulfenic acid in live cells with dimedone-based probes 1 and 2.  
2.1.1 Sample preparation and cell treatment. The relevant solutions of 1 and 2 for the detection of 
sulfenylation in live cells were prepared freshly before each experiment. Briefly, a 100 mM solution 
of 1 or 2 in dimethylsulfoxide was obtained by dissolving the solid powder and further dilute to 10 
mM in DPBS. From the latter, the working solutions ranging from 0.05 to 1 mM in final 
concentration were prepared by dilution either in DPBS or in DMEM without FBS (DMEM-) as 
indicated in the relevant discussion. Before the addition of the solution containing 1 or 2, the 
growing media containing FBS was removed and the adhered cells were washed three times with 
abundant DPBS to remove any trace of FBS. Finally, 100 µL of 1 or 2 working solution was added 
into each well and incubated for 15 minutes at 37 °C before the start of each experiment. For each 
set of experiments samples were prepared in triplicate. 
2.1.2 Protein sulfenylation in live cells in response to exogenous H2O2. For the detection of 
sulfenylation in live cells under exposure to H2O2, cells were pre-treated for 15 minutes in DPBS or 
DMEM- containing 1 mM of 1 or 2. A 100 mM solution of H2O2 was obtained from the 30% w/w 
in water stock solution (Sigma-Aldrich, #H3410) immediately before use in DPBS and then added 
to the pre-treated sample containing 1 or 2 to the desired final concentration of H2O2 in the wells.   
2.1.3 Co-staining of protein sulfenylation and mitochondria. For mitochondria staining and co-
localization experiments with 1 or 2, the MytoTracker™ Deep Red (Invitrogen, #M22426) was 
used following the manufacturer instruction. Briefly, cells were incubated with the desired 
concentrations of 10, 25, 50 and 100 nM of MytoTracker™ for 30 minutes in DMEM+. After the 
incubation step, the media was removed, cells were washed with DPBS and DMEM- containing 1 
mM of 2 was added (incubated for further 30 minutes). 
2.1.4 Assessing protein sulfenylation in response to cis-platin treatment. MCF7 and MDA-MB-231 
were treated for 1 hour in DMEM+ containing 1, 10 or 25 µM cisplatin obtained by dilution from a 
3.3 mM (1 mg/mL) stock solution 150 mM in NaCl and 0.01 % w/v in mannitol. After incubation, 
media was removed and cells were washed three times with DPBS to remove FBS and then 
incubated with DMEM- and 1 mM of probe 2 for 30 minutes.  
2.1.5 Cell fixation and removal of unbound dimedone-based probes. After each experiment, 
samples were prepared for fluorescent microscopy analysis as follows: to remove the excess of 1 or 
2, the solution in the wells was removed and cells were rinsed three times with DPBS. Cells were 
fixed by treatment with a 70% ice-cold ethanol solution in DPBS v/v for 40 minutes on ice. Then, 
the 70% ethanol solution was removed and cells rinsed five times with DPBS at room temperature. 
Finally, the wells were filled with a 50 % w/v glycerol (Sigma-Aldrich, Bio-Reagent purity grade) 
in DPBS to perform microscopy analysis. 
2.2 Light Fluorescence Microscopy. These studies were carried out with a Nikon Eclipse-Ti 
inverted microscope equipped with motorized stage and perfect focus system (PFS) to address focus 
drift in axial fluctuation during tile scan acquisition. The NIS-Elements Nikon software was used 
throughout the microscopy experiments to control the stage movement, exposure time in individual 
channels and camera recording set up. The Intensilight Hg lamp illumination system (Nikon) was 
used throughout the experiments for excitation of fluorophores in the samples in combination with 
the appropriate dichromatic beam splitter filter cubes for the wavelengths of interest. For 1, a UV-
2B filter cube was used (λex= 330-380 nm; DM= 400 nm LP; λem = 435 nm LP). For 2, a HYQ-
FITC cube was used (λex= 460-500 nm; DM= 505 nm LP; λem = 510-560 nm). Nuclear staining with 
4,6-diamidino-2-phenylindole (DAPI) was visualized with a DAPI filter (λex= 325-375 nm; DM= 
400 nm LP; λem= 435-485 nm). Mitochondria signal from MytoTracker™ Deep Red staining was 
obtained with a CY5 HYQ filter (λex= 590-650 nm; DM= 660 nm LP; λem= 663-738 nm). For each 
experiment, a tile scan of 10x10 fields of view (5120 𝑝𝑥 × 5120 𝑝𝑥; 0.27
𝜇𝑚
𝑝𝑥
; 1382 𝜇𝑚 ×
1382 𝜇𝑚 → 1.94 𝑚𝑚2) in each individual channel was acquired with a Nikon 60x, NA 1.49, oil 
immersion objective and the epifluorescence signal was collected with an Andor iXon DU-897 
EMCCD camera set at 16-bit, with an overclocked readout at 1 MHz and conversion gain at 2.4x, 
with the electron multiplier set at 80. 
 
3. Results and Discussion 
3.1 Synthesis of the dimedone-based optical probes 
The coumarin-based optical probe 1 was synthesized via six steps as shown in Scheme 1.  
Succinimidyl-activated 7-methoxycoumarin-3-carboxylic acid 4 was obtained as previously 
reported [35] and reacted with commercially available N-Boc-1,4-butanediamine 5 to yield 
compound 6. After standard TFA-mediated protecting group removal, intermediate 7 was coupled 
with the previously described dimedone analogue 9 [27], using EDC, HOBt and Et3N. The removal 
of the methyl group from intermediate 10 was carried out using LiOH to yield probe 1.  
 
Scheme 1. Synthetic route for coumarine-based optical probe 1 and EDANS-based optical probe 2. 
Reagents and conditions: a) NHS (1 equiv), DCC (1.1 equiv), DMF, 5.5 h, 0°C → rt; b) DMAP 
(0.1 equiv), DIPEA (2 equiv), 5 (0.95 equiv), CH2Cl2, N2, 5 h, rt; c) TFA/CH2Cl2 1:3, 1.5 h, rt; d) 
TsOH (0.05 equiv), CH3OH, 1 h, rt; e) HOBt (1.0 equiv), Et3N (1.4 equiv), EDC (1.4 equiv), 9 (1.1-
1.4 equiv), DMF, N2, 24-48 h, rt; f) LiOH (4 equiv), THF/MeOH/H2O 4:1.6:1.6, 16 h, rt; g) CAN 
(0.1 equiv), CH3CN/H2O 1:1, 6 h, 100 °C. 
 
In parallel, EDANS-based optical probe 2 was synthesised in three steps (Scheme 1). Commercially 
available EDANS fluorophore 11 was reacted with the protected dimedone derivative 9 [27] to 
generate intermediate 12 through the same coupling conditions used to synthesise compound 10 
(Scheme 1). The methyl removal on 12 was performed with cerium(IV) ammonium nitrate [36] to 
afford the EDANS optical probe 2.  
The identity and purity of 1 and 2 were confirmed by a combination of analytical and spectroscopic 
techniques (i.e. HPLC, 1H and 13C NMR spectroscopy, HR-MS and IR spectroscopy – see 
Supporting Information). The emission spectra for 1 and 2 were recorded and the 
excitation/emission wavelengths (λex/λem) are: 348/403 nm and 335/500 nm respectively. 
 
3.2 Sulfenic cysteine labelling and detection via microscopy approaches in live MCF7 cells  
We first established that the probes were cell permeable (see Figure 3) and non-toxic at the 
concentrations required for imaging (see below for discussion). Subsequently, we determined their 
optimal concentration for the best signal-to-noise ratio in cellular imaging experiments employing 
the MCF7 breast cancer cell line. In addition, as a control, we recorded the fluorescence of the 
probes before and after addition of H2O2 to verify that the oxidant did not modify their 
photophysical properties; no major changes on the emission of the probes were observed (see 
Figure S1, Supporting Information).   
Initially, different concentrations of 1 and 2 were tested in the absence/presence of 1 mM H2O2 
(Figure 2). H2O2 is known to modulate signal transduction through oxidation of cysteine residues in 
proteins and is the oxidant of choice to study redox behaviours in cellulo [22,25]. Given the 
kinetically labile nature of the SOH moiety and its dependency on the redox state of the cell 
[1,11,14], it is expected that the presence of the reactive dimedone probe in the cell prior the 
treatment with H2O2 would allow a faster and more quantitative trapping of sulfenic groups while 
they form during an oxidative burst. Thus, live MCF7 cells were pre-treated for 15 minutes with 
either 1 or 2 in order to allow diffusion of the probe within the cell compartments prior to the 
beginning of each experiment. After incubation with the probes, H2O2 was added directly into the 
wells to a final concentration of 1 mM for the treated sample, whereas the controls were not 
exposed to H2O2, and cells were further incubated for 30 minutes under normal conditions. 
Immediately after, cells were fixed with a 70% ice-cold ethanol solution and extensively washed to 
remove the unbound probe before analysis by fluorescent microscopy (see Methods for details).  
The mean single cell fluorescence intensities of both probes 1 and probe 2 were calculated by 
scanning the image of a 1.9 mm2 area in each well representing a single experiment and then 
identifying single cells in the scanned area. In order to extract quantitative information from the 
signals in the fluorescent channel of the probes, we developed an in-house method (macro run code 
available in the Supporting Information) in Fiji software for the quantification of the single cell 
fluorescent intensity as depicted in Figure S2. Briefly, the entire image acquired in each channel of 
interest was flattened to correct the illumination profile in the field of view and background 
subtracted. Single cell boundaries were identified to calculate the mean signal intensity from each 
individual cell, expressed as the ratio between the total pixel intensity and the integrated area within 
the cell boundaries. The identification of single cell boundaries was achieved via thresholding of 
pixel intensity between the background and the cell signal and used to create a mask for the 
algorithmic identification of each single cell in the whole area of the image with defined size and 
circularity after appropriate segmentation of touching cells (Figure S2). The results obtained using 
either probe 1 and 2 are shown in Figure 2. For increasing concentration of the probes (i.e. 0.05, 0.2 
and 1 mM) in the absence of H2O2 (blue bars), the mean intensity of single cell fluorescence 
appears constant for probe 1 and with a proportional increase for probe 2. These differences might 
be attributed to the distinct reactivity of each probe as well as their solubility and consequently 
cellular distribution. The sulfonic acid moiety of the EDANS fluorophore confers higher water 
solubility to 2 and may allow a faster and more homogeneous diffusion of this probe within the 
cytosol, resulting in a more efficient trapping of SOH groups within the cell compartments. 
Furthermore, the auto-fluorescence signal in the blue-green fluorescent channels arising from 
intrinsic cell compounds like NAD(P)H, collagen and riboflavin was found to be below the 
intensity of the lowest concentration of probes tested (0.05 mM) in both the UV and FITC channels 
used to visualize 1 and 2, respectively (Figure S3, Supporting Information). These observations 
highlight the ability of our probes to monitor the presence of SOH groups at the basal level of 
protein oxidation in MCF7 cells with 2 displaying a clear dose-dependent behaviour.  Furthermore, 
when the cells were treated with 1 mM H2O2 (red bars in Figure 2) a marked increase in the mean 
fluorescent signal intensity for single cells was recorded for both probes. The increase in signal was 
found proportional to the increase in concentration of the probe used in each experiment, showing 
the selective response of the probes to hydrogen peroxide treatment (associated to SOH formation). 
 
Figure 2. Mean intensity signal from MCF7 cells treated in absence and with increasing 
concentrations (i.e. 0, 0.05, 0.2 and 1 mM) of probes 1 (DAPI channel) and 2 (FITC channel). Blue 
bars represent the basal levels of SOH measured, whereas red bars show the SOH levels after 
treatment with 1 mM H2O2 in DPBS for 30 minutes at 37°. Error bars are the standard errors of the 
mean.  
 
We found that the best ratio between the H2O2-treated versus the untreated sample was achieved 
using 1 mM concentration of the probes. Therefore, this concentration was chosen for all 
subsequent experiments. Figure 3 shows representative images acquired for MCF7 cells before (3A, 
C, E, G) and after (3B, D, F, H) treatment with 1 mM H2O2 in the absence (Figure 3, top row) or 
presence (Figure 3, bottom row) of the probes at 1 mM concentration. These images show 
significantly higher emission intensity for H2O2-treated cells compared to the untreated ones with a 
2.4-fold and 4.1-fold increase for 1 and 2 respectively, indicating the ability of both probes to 
discriminate SOH in MCF7 cells at their basal level and in response to the exogenous oxidative 
stimuli with H2O2.  
 
Figure 3. Representative fluorescent microscopy images for MCF7 cells treated with probe 1 (left 
panel, cyan colour for the 403 nm emission wavelength in the DAPI channel) and probe 2 (right 
panel, green colour for the 500 nm emission wavelength in the FITC channel). Images A-B (probe 
1) and images E-F (probe 2) show the auto fluorescence signal before and after treatment for 30 
minutes at 37 ºC with 1 mM H2O2, respectively. Images C-D (1) and G-H (2) show MCF7 
fluorescence signal in the presence of the probes at 1 mM concentration to reveal the presence of 
sulfenic acid groups before and after exposure to 1 mM H2O2 for 30 minutes at 37 ºC. White arrows 
in each image show the nuclei localization to facilitate cell identification. Calibration bar for pixel 
intensity: range 0 – 2100 a.u.; scale bar 20 micron.  
 
Considering that the probes were used in the mM range, we evaluated their possible cytotxicity on 
MCF7 cells by monitoring the cell growth after incubation for 30 minutes at 37 ºC with the probes 
at 1 mM concentration. Being allowed to adhere for 24 hours, cells were firstly imaged in bright 
field for density and morphology evaluation before the treatment. After treatment with the probes, 
cells were washed to remove the excess of probes, replenish with fresh media and leave to grow 
under normal conditions. MCF7 cells were monitored for three days and no differences were 
observed in cell morphology and growth compared to control samples of untreated cells (see Figure 
S4).  This indicates that the probes are not cytotoxic at the concentration (i.e. 1 mM) needed for 
imaging and quantification of sulfenic acids in our methodology. Considering the higher sensitivity, 
its cellular distribution and no apparent cytotoxicity, we used probe 2 to carry out further 
investigation on SOH formation in cells. 
 
3.3 Cellular localization and levels of protein sulfenylation in MCF7 and MDA-MB-231 breast 
cancer cell lines 
We next investigated the sub-cellular localization of SOH residues at the basal level and after 
oxidative stress induced by H2O2 treatment. In addition to MCF7, we also performed experiments 
on a second breast cancer cell line, namely MDA-MB-231. Despite both being breast cancer cell 
lines, MCF7 and MDA-MB-231 are well known to differ in many aspects. MCF7 is a luminal 
breast cancer cell line with an epithelial-like morphology and it is widely used as in vitro model for 
oestrogen and progesterone receptor positive breast cancer studies. On the other hand, MDA-MB-
231 is a basal breast cancer cell line with a mesenchymal-like morphology with a complete lack of 
hormonal receptors which is widely used as in vitro model for triple negative breast cancer, a more 
malignant, invasive and chemo resistant type compared to MCF7 phenotype [37]. We hypothesized 
that the different molecular features between the two cell lines could results in distinct responses in 
respect to the production of SOHs when stimulated by exogenous oxidative stress.  Figure 4 shows 
the microscopy images after incubating the cells with probe 2 (1 mM, 30 minutes) before and after 
treatment with H2O2.  
 
Figure 4. Microscopy images for MDA-MB-231 (top) and MCF7 (bottom) cells treated with 1 mM 
of probe 2 before (left) and after (right) exposure to 1 mM H2O2. Blue channel: DAPI; green 
channel: FITC (2). Images are shown with a contrast suitable to highlight the SOH localization in 
each cell line. For MDA-MB-231, pixel range intensity shown is 100-3000; for MCF7 the pixel 
range intensity shown is 100-800. 
 
From these experiments, the staining pattern highlights the presence of SOHs in the perinuclear 
region of the cells with a punctate nature which becomes more pronounced after incubation with 
H2O2. We recorded major differences between the two cell lines in terms of signal intensity 
assocaited to the detection of SOHs. Interestingly, for the basal levels of SOHs we found a 7-fold 
lower intensity in MCF7 than MDA-MB-231 cells, which suggest different levels of SOH for the 
two cell lines during their normal proliferation in standard growing conditions. After treatment with 
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DAPI FITC Merged DAPI FITC Merged
20 mm
20 mm
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1 mM H2O2, the MCF7 cells showed a 4-fold increase in SOH signal whereas for the MDA-MB-
231 we recorded a 1.5-fold increase, relative to their starting basal levels. These data support 
previous findings showing variable basal levels of SOHs in different cells [38-40], which may be 
related to differences in the redox state of each specific cell line [41-43]. Noteworthy, we observed 
a distinct response between the two cell lines to the oxidative stress caused by treatment with H2O2, 
with the MCF7 being 2.6 times more susceptible than MDA-MB-231 in increasing the amount of 
SOHs following the addition of H2O2. While we cannot discard the possibility that the differences 
observed between the cell lines may be partially due to differences in the probe’s cellular uptake, 
this is unlikely to account for a 7-fold increase in intensity in MDA-MB-231 as compared to MCF7. 
Our data reveal that an intrinsic difference in the basal levels of protein sulfenylation exists for the 
two different cell lines, which could be due to differences in: i) the overall redox state of the cell 
and its subcellular compartments (i.e. ROS levels); ii) the diverse signalling pathways responding to 
increased oxidative stress (which we mimic with a burst of exogenous H2O2).  
 
3.4 Oxidation in mitochondria contributes to protein sulfenylation at the basal level in MCF7 but 
not in MDA-MB-231 
Being the organelles in the cell responsible for the energy (ATP) production, mitochondria are 
known to produce endogenous ROS species during the process of cellular respiration. As a 
consequence, high levels of protein oxidation are found in mitochondria and hence they represent 
an ideal site for the formation of protein-SOH groups [44-46]. Considering that probe 2 showed a 
punctate staining pattern in the cell lines under study (see Figures 3 and 4), we hypothesised that 
SOH formation could be derived, at least partially, by the activity of mitochondria and, 
consequently, localized in their proximity. With this aim, we investigated the localisation of SOH 
modifications by using 2 in combination with the mitochondria-specific probe MytoTracker™ Deep 
Red (MDR) – a well-established dye that accumulates preferentially in active mitochondria; λem= 
665 nm), but covalently binds to the free sulfhydryl groups (SH) within the active mitochondria. 
Figure 5 shows representative images for MCF7 and MDA-MB-231 cells after pre-incubation with 
MDR for 30 minutes, followed by treatment with 2 (1 mM) for a further 30 minutes to trap sulfenic 
acid moieties at the basal levels in the two cell lines. As can be seen, we found significant co-
localisation of both dyes in MCF7 cells indicating the presence of SOH groups in mitochondria (co-
localization range: 34-72%). This is analogous to previous studies with a different dimedone-based 
fluorescent probe in Chang liver cells, which also showed higher levels of protein oxidation in 
mitochondria [28]. 
Interestingly, our studies showed that there is minimal co-localisation of 2 and MDR in 
mitochondria, in the case of MDA-MB-231 cells (co-localization range: 8-22%), with a narrower 
distribution of probe 2 in the perinuclear region of the cells. These results suggest a different 
distribution of SOH groups in the cellular compartments, especially in the light of a 7-fold higher 
level of protein sulfenylation found at basal level for MDA-MB-231 compared to MCF7 (Figure 4).  
 
Figure 5. MCF7 cells (top) and MDA-MB-231 (bottom) stained for 30 minutes with 100 nM of 
MDR (Cy5-red channel) and probe 2 for the detection of protein sulfenylation (FITC-green 
channel). Nuclei are stained in blue (DAPI channel). From the merged image the yellow represent 
the co-localized signal of mitochondria and sulfenic acid groups. Contrast for DAPI and Cy5 
50 mm
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channels are the same for the top and bottom images. Contrast for 2 in the FITC channel differs 
between top and bottom images to better visualize the cellular localization of SOH groups. 
 
The differences in co-staining for the two cell lines might be due to the availability of free SH 
groups (which represent potential sites for the formation of SOH groups), which in turn might be 
affected by the MDR probe. MDR binds covalently to thiol groups in proteins through the thiol-
reactive chloromethyl moiety, facilitating its retention during the fixation procedure. Therefore, the 
presence of MDR could reduce the formation of SOH derivatives by blocking some of the available 
thiol groups within the mitochondria from oxidation by endogenously produced ROS. To 
investigate this further, MCF7 and MDA-MB-231 cells were treated for 30 minutes in complete 
media containing MDR at 10, 20, 50 and 100 nM concentrations prior to the addition of 2 (1 mM). 
As shown in Figure 6, the single cell frequency distribution of 2 (green plots) is characterised by a 
shift towards lower intensities, which is in an inversely proportional fashion to the increase of MDR 
signal (red plots) in the sample for MCF7 cells but not for MDA-MB-231. The behaviour observed 
for MCF7 suggests the presence of a dynamic formation of protein SOH groups within the 
mitochondria due to the availability of free protein SH groups and endogenous ROS species within 
the experimental time frame (30 minutes). By covalently blocking the free protein SH groups we 
were able to detect a decrease in SOH formation with increasing concentration of MDR. In contrast, 
the MDA-MB-231 cell line behaved differently, indicating a more pronounced oxidation of thiols 
(SHs) to SOHs within the mitochondria, as demonstrated by the higher 7-fold intensity found at the 
basal level (Figure 4).   
Overall, the results show the presence of multiple sites of SOH formation which in part occurs 
within mitochondria, as well as in the perinuclear region of the cells where it has been already 
observed before in connection with the endoplasmic reticulum (ER) [47,48].  
 
 Figure 6. Single cell distribution plots for MCF7 (left panel) and MDA-MB-231 (right panel) 
treated with increasing concentrations of MDR (red plots) and 1 mM of 2 (green plots) to measure 
protein sulfenylation localized in the mitochondria. Cell were pre-treated for 30 minutes with 
increasing amounts of MDR as indicated in the plots, followed by incubation for additional 30 
minutes with 2 (1 mM). Standard error of the mean was ≤1% of the mean values for the MDR 
signals and ≤5% of the mean values for the FITC channel for probe 2 signal. 
 
3.5 Protein sulfenylation response to cisplatin-induced oxidative stress 
The treatment of cell lines with the anticancer agent cisplatin is known to promote apoptosis 
through a variety of mechanisms, including the disruption of their redox state [31,49,50]. On the 
other hand, protein sulfenylation is highly dependent on the variation in the redox state within the 
cell and is reversible, therefore acting as a dynamic, non-definitive signal modification in the 
response mechanism to cellular stress. In in vitro experiments, cisplatin reduces the cell viability 
and the proliferative capacity at the doses commonly reached in tissues (10-20 mM) in clinical 
treatments [33,34]. Interestingly, MCF7 and MDA-MB-231 exhibit a different susceptibility to 
cisplatin, with the MCF7 showing the faster decrease in cell proliferation and viability compared to 
the MDA-MB-231 [51]. In MDA-MB-231, cisplatin toxicity appears closely related to a general 
increase in ROS production and a fast reduction in oxygen consumption immediately after 
administration, whereas in MCF7 changes are visible only after 5-6 hours [41,52]. On the other 
hand, cisplatin accumulates in the mitochondria which have been proposed as primary targets for 
cisplatin-mediated DNA damage [34,50]. There have also been studies showing that cisplatin 
derivatives induce the formation of sulfenic acid in cysteine Cys34 from Human Serum Albumin 
[53].   
Having established the ability of 2 to image SOH in cells, we were interested in applying this probe 
to study a process in which cells are subjected to endogenous oxidative stress by the addition of 
cisplatin. In Figure 7, we show the microscopy results for the treatment of both cell lines (MCF7 
and MDA-MB-231) with 1, 10 and 25 µM cisplatin administered for 1 hour followed by incubation 
with 2. 
 Figure 7. Single cell distribution for protein sulfenylation detected with probe 2. From top to 
bottom: dose-dependent treatment with cisplatin at (A-E) 0, (B-F) 1, (C-G) 10 and (D-H) 25 µM. 
Left panel: representative images for MCF7 cells in DAPI (blue channel), FITC (green channel for 
probe 2) and merged channels of the single cell distribution plots for the tested concentrations of 
cisplatin. Right panel: representative images for MDA-MB-231 cells in DAPI (blue channel), FITC 
(green channel for probe 2) and merged channels of the single cell distribution plots for the tested 
concentrations of cisplatin. Red stars in each distribution plot represent the mean value of the 
population distribution.  
 
The MCF7 cells showed increased protein sulfenylation when they were treated with increasing 
concentrations of cisplatin, with a general shift of the entire population towards higher signal 
intensities (Figure 7A-D). Furthermore, a small fraction of the cell population with higher levels of 
SOHs already appears at the low dose of cisplatin administered (1 mM, Figure 7B) and further 
increases at higher doses, contributing to a heterogeneous response within the overall population. 
On the other hand, the MDA-MB-231 cell line (Figure 7E-H) shows an equal and modest increase 
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in the mean value of the protein sulfenylation across the entire range of cisplatin concentrations 
compared to the control sample. In MCF7 cells the signal from SOH groups appears initially 
localized in the perinuclear region at the basal level (Figure 7A). With the increase in cisplatin 
concentration during treatment, the signal intensity increases in the perinuclear region and it extends 
into the surrounding cytosolic fraction, as well as localises in the mitochondria with a punctate 
nature (Figure 7B-D). In contrast, the staining of SOH groups in MDA-MB-231 appears not 
punctate in nature and narrowly localized in the perinuclear region of the cells in the control as well 
as in the cisplatin treated samples (Figure 7E-H). We found that the MCF7 cells hold: i) a higher 
potential than MDA-MB-231 in terms of SOH formation after treatment with 1 mM H2O2 (i.e. 4-
fold increase in MCF7, 1.5-fold increase in MDA-MB-231) and ii) a significant difference in the 
presence of SOH groups at the basal level (i.e. 7-fold lower SOH signal for MCF7 than MDA-MB-
231). These observations suggest an active and dynamic role of protein sulfenylation in response to 
cisplatin damage. For cells with a low presence of SOH groups at the basal level (i.e. MCF7), the 
oxidative stress introduced by cisplatin prompts a rapid increase in SOHs that is proportional to the 
dose administered, a behaviour not mirrored in the MDA-MB-231 cells which have a higher basal 
level of SOH and can therefore progress to higher oxidative species like sulfinic and non-reversible 
sulfonic acids after cisplatin-induced stress.  
 
4. Conclusions 
In this work, we have developed two new fluorescent probes (1 and 2) for the direct detection and 
optical visualization of protein sulfenic residues. The two probes are cell permeable and not 
cytotoxic at the concentrations needed for cellular imaging allowing us to carry out a range of 
imaging studies in cells. Both these probes are able to detect the increase of SOH cellular levels 
upon treatment with H2O2. Probe 2 – while not as bright as a previously reported dimedone-based 
probe with 7-aminocoumarin [28] – has shown to have higher sensitivity and solubility than 1, as 
well as a more punctuated localisation in perinuclear regions of the cell. Co-staining microscopy 
studies with 2 and the well-established dye MDR demonstrate the presence of high levels of SOHs 
in mitochondria. Our observations also highlight different basal levels of SOH oxidation between 
two cell lines, with MCF7 cells showing a higher level of SOH formation in mitochondria with 
respect to MDA-MB-231 cells. We subsequently used probe 2 to monitor changes in protein 
sulfenylation in cells upon treatment with cisplatin. As expected, addition of the drug resulted in 
higher levels of SOHs which were detected by our probe (likely due to protein oxidative stress 
associated with cisplatin treatment).   
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